The current application of stem cell based therapy in pulmonary hypertension / 药学学报
Acta Pharmaceutica Sinica
;
(12): 1778-1783, 2018.
Artículo
en Chino
| WPRIM
| ID: wpr-780058
ABSTRACT
Pulmonary hypertension (PH) is a progressive cardiopulmonary disease with high mortality and increased prevalence. The target therapy of pulmonary hypertension is mainly dependent on vasodilation, but how to improve vascular remodeling with stem cell therapy has not been fully understood. Over the past ten years, the researches on endothelial progenitor cells, mesenchymal stem cells and pluripotent cells have brought the hope to patients with pulmonary hypertension. This article mainly introduces the latest progress of stem cell technology in the intervention of pulmonary hypertension, and discusses the problems in the application.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Acta Pharmaceutica Sinica
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS